Table 4.

Adverse events of MC categorized according to the National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) version 4.

	Any grade N patients (%)	Grade 1–2 N patients (%)	Grade 3–4N patients (%)
Overall	12 (34.3%)	8 (22.8%)	2 (5.7%)
Fatigue	6 (17.1%)	6 (17.1%)	0
Hand-Foot skin reaction	3 (8.5%)	2 (5.7%)	1 (2.9%)
Thrombocytopenia	3 (8.5%)	1 (2.9%)	2 (5.7%)
Neutropenia	2 (5.7%)	2 (5.7%)	0
Anaemia	1 (2.9%)	1 (2.9%)	0
Bilirubin elevation	1 (2.9%)	1 (2.9%)	0
Nausea/Vomiting	1 (2.9%)	1 (2.9%)	0
Mucositis	1 (2.9%)	1 (2.9%)	0